THC Farmacuticals, Inc is trading on the OTC Markets under the trading symbol CBDG. THC Farmaceuticals, Inc engages in the research and development of cannabis pharmaceutical products. Through its subsidiaries, CBDG is involved in research and development of unique cannabis formulations, edibles and delivery systems of cannabis. It manufactures and markets cannabis extract products made from cannabis. The company was founded in April 2005 and is headquartered in Thousand Oaks, California.